The iconic rise of Viagra has long been a symbol of pharmaceutical success, however its legacy within the broader industry now triggers questions about long-term returns . Copycat versions are diminishing patent protection , leading to anxieties that supporting companies significantly dependent to Viagra's former position could be a problematic dec